Form D · Other
VIN-5 NOB HILL THERAPEUTICS, LLC
Fayetteville, AR · CIK 0001688879
Offering snapshot reported Oct 31, 2016 · SEC filing
- Reported sold
- $113K Offering amount: $250K
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $6.25K Reported outside-investor minimum
- First sale
- Oct 26, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 31, 2016 | Initial | $112,500 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-273514
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Oct 31, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| R. Calvin Goforth | Director, Executive |
| Mark Kidd | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
535 W Research Center Blvd. Suite 135
Fayetteville, AR, 72701
Fayetteville, AR, 72701